Abbott Laboratories (ABT): A Healthcare Leader Offering Dividend Value and Growth

Abbott Laboratories (NYSE:ABT) is included among the 11 Best Value Dividend Stocks to Buy Now.

Abbott Laboratories (NYSE:ABT) produces a wide range of healthcare products and medical devices, with its business divided into four main areas: established pharmaceuticals, diagnostics, nutrition, and medical devices.

On September 19, Abbott Laboratories (NYSE:ABT) declared a quarterly dividend of $0.59 per share, which was in line with its previous dividend. Overall, the company has raised its payouts for 53 years straight, which makes it one of the best value stocks with dividends. The stock supports a dividend yield of 1.77%, as of September 26.

The pandemic gave Abbott Laboratories (NYSE:ABT) a major lift through strong demand for its rapid COVID-19 tests. While sales in this category have since dropped, the company’s core operations continue to perform well. One of its standout products is the FreeStyle Libre, the world’s best-selling continuous glucose monitoring system, which has become a major driver of growth thanks to its rapidly increasing sales.

While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 11 Best Telecom Dividend Stocks to Buy for 2025 and 11 Best Bank Dividend Stocks to Buy.

Disclosure: None.